Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
about
Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgiaHerpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveRisk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort StudyLooking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.No increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan.Systematic review of incidence and complications of herpes zoster: towards a global perspective.Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses.Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in TaiwanA nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster.Evaluation of the economic burden of Herpes Zoster (HZ) infection.Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan.Annual incidence rates of herpes zoster among an immunocompetent population in the United States.Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective SurveyLongitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study.Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study.Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infectionsThe Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study.Adult asthma is associated with an increased risk of herpes zoster: A population-based cohort study.Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients.Dyshidrosis is a risk factor for herpes zoster.Increased incidence of herpes zoster in adult patients with peptic ulcer disease: a population-based cohort study.Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan.Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study.Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study.Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.
P2860
Q24606799-81B63847-96ED-4137-8131-A8DA690C1551Q26781940-46DF1F1B-6D41-4384-9807-2BF8939E31ECQ28547474-80E8D245-EDCE-45A6-8EB9-BB6FE2072C62Q30235260-8138411D-F453-440E-98A7-FDFEB8935970Q31156767-AA8AA829-D13F-4A2E-93F3-3FA64BAD9E37Q33795551-B9ED068E-1B55-4173-8E94-AACAE9AA708FQ34125709-6864ED91-B132-4C54-B551-ECCB3E0B9A92Q34462774-C224706B-55EB-4740-86DD-0C279B0EBAB5Q35016212-CA7E105C-15AF-4C62-83BB-3C835BDE11D3Q35498396-D60115DC-6C3F-49BD-8260-DE343A07DA35Q35660885-CB6D4429-9F67-498B-A84B-2FFAB32869DBQ35834938-090CC0C4-C3B7-486E-BC05-824782D065A1Q35982768-A4A54F44-9B50-4246-862D-09668998FA06Q36099232-7ECC4CC0-276B-4448-8432-E696DFA1D37DQ36155105-3F2FE58E-7727-4674-8CD4-38AF2EF028BCQ36225734-D1336F62-0E16-4522-9D70-437295977583Q36461527-97B9BB5C-473A-4FC3-AA9E-B7B5E7AAF59BQ37205138-E5D46B21-6EE2-4B16-8912-5D050270CD49Q37234339-968C530E-E356-40D4-AD81-F6122B3E97C0Q39606086-EFFBF812-9ABC-4829-A0C2-B7038C640167Q40116120-B1714F8C-A030-438F-AC4D-1845A398C9ABQ41007667-BC950729-1156-4B9B-80FB-2BB0A21CDB11Q45718575-1C088E98-8082-450A-8FB0-1CBDC9FCDFF0Q47116379-883BD01B-4584-407B-86B2-D006E99E3107Q48065774-1B33123A-7112-4163-BE5F-D6C78DACAEB9Q50115825-EDF42EE6-0CC5-4FF5-B429-B2A98205A0D0Q51761737-CCBB486D-8805-4A6A-8067-4EC485B6CED4
P2860
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@en
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@nl
type
label
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@en
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@nl
prefLabel
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@en
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@nl
P2093
P50
P1433
P1476
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
@en
P2093
Advisory Committee on Immunization Practices, Taiwan
Fang-Yu Tsai
I-Shou Chang
Pei-Lan Shao
Varicella-Zoster Working Group
Yung-Hsiu Lin
P304
P356
10.1016/J.VACCINE.2009.11.029
P407
P577
2009-11-26T00:00:00Z